# Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk

Source: [nature.com](https://www.nature.com/articles/s41588-026-02843-0) · 2026-11-17 · Life
Page: https://themorning.science/story/integrated-qtl-mapping-and-crispr-screening-in-pooled-ipsc-derived-microglia-rev-325d5082ad196a48
Kind: research · Impact: medium

## In brief

- Published online in Nature Genetics on 17 November 2026 (doi:10.1038/s41588-026-02843-0).
- Presents a scalable framework combining QTL mapping and CRISPR screening in pooled iPSC-derived microglia-like cells.
- Aims to link genetic determinants of gene expression and cellular phenotype to neurodegenerative risk.

## Why it matters

It offers a method for connecting genetic variants to microglial gene expression and cell behaviour, which can help identify genetic drivers of neurodegenerative disease risk.

## Timeline

- 2026-11-17: Study published online in Nature Genetics

## Coverage

- [Integrated QTL mapping and CRISPR screening in pooled iPSC-derived microglia reveals genetic drivers of neurodegenerative risk](https://www.nature.com/articles/s41588-026-02843-0) — nature.com, 2026-11-17

Tags: microglia, crispr screening, qtl mapping, ipsc, neurodegeneration, genetics

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
